Pharmaceutical development with commercialization of generic drugs with poor soluble substance – tablets of drug nimodipine

Journal Title: Фармацевтичний журнал - Year 2017, Vol 3, Issue 3

Abstract

The pharmaceutical development of solid dosage forms which containing a poor soluble substance deserves special attention, because a composition and a technology of production such drugs directly effects on release the active pharmaceutical ingredient in the human body and, as a consequence, on pharmacological effectiveness of this drug. The search of therapeutically effective, economically viable and industrially reproducible technology for the production of such drugs is very important for the pharmaceutical industry. The purpose of our work was the pharmaceutical development of the generic drug, which contains a poor soluble in water substance nimodipine. The subject of the research is the substance nimodipine and the samples of tablets obtained with the help of various technological methods from this substance. All analytical and pharmaco-technological researches were implemented according to generally accepted methods that accordance with the requirements of the State Pharmacopoeia of Ukraine. Laboratory batches were developed using technological methods of physical modification of a substance, such as: micronization, sonocrystalllization, solid dispersion by melting, solid dispersion by solvent evaporation, complexation with β-cyclodextrins. Researches of the comparative in vitro dissolution kinetics of substance nimodipin from these laboratory batches made it possible to establish optimal technology for the commercial production of a generic drug. Researches on influence quantity of disintegrant and lubricant in the composition of tablets on the pharmacopoeial parameters of the quality were done. According to the results of the pharmaceutical development, it can be argued that the use of the technological method for production a solid dispersion with the aid of a solvent is most appropriate for the production of tablets of a generic drug with a substance nimodipine, which is confirmed by the results of the comparative in vitro dissolution kinetics in three media and clinical trials. The required quantity of disintegrat (not less than 2.5% per tablet) and lubricant (not less than 0.4% per tablet) in the composition of generic tablets were defined.

Authors and Affiliations

O. E. Schykovskiy, Т. V. Кrutskikh

Keywords

Related Articles

Antioxidant properties of hidazepam and amitriptyline with pain syndrome of rats

Peroxide modification of cell biostructures and functions due to the activation of free radical oxidative processes underlies the pathogenesis of a significant number of diseases different in its etiology. The ability of...

Justification of technology of extemporaneous suppositories for prostatitis treatment based on the medicine «Trezivit-prost»

Chronic abacterial prostatitis is one of the most common diseases among the male population, both in Ukraine and abroad. Pharmaceutical compounding in conditions of the pharmacy allows individual selection of active subs...

The choice of intense sweetener in the composition of medicated chewing gum under development

Considering the simplicity and ease of use, in recent years, more and more attention deserves medicated chewing gum (MCG), which plays the role of oral drug delivery system. Since this product remains in the oral cavity...

Approaches to optimize pharmaceutical and medical care of patients with psoriasis

Features of psoriasis as chronic inflammatory disease, frequent recurrence, the short periods of remission, psycho-emotional disadaptation, decline in quality of patient life and unsatisfied need for safe and effective t...

Comparative phytochemicals analysis of raw materials of Lupinus luteus L. and Medicago falcata L. subsp. romanica (Prodan) O. Schwarz & KLink. after hydrolysis

Lupin in folk medicine used against abscesses, birthmarks, to excite the appetite. Alfalfa in folk medicine used for diseases of the intestine, stomach, thyroid, to improve metabolism, normalization of the circulatory s...

Download PDF file
  • EP ID EP556052
  • DOI 10.32352/0367-3057.3-4.17.07
  • Views 45
  • Downloads 0

How To Cite

O. E. Schykovskiy, Т. V. Кrutskikh (2017). Pharmaceutical development with commercialization of generic drugs with poor soluble substance – tablets of drug nimodipine. Фармацевтичний журнал, 3(3), 60-70. https://europub.co.uk/articles/-A-556052